Helicobacter Pylori Testing Market
Number of pages: 100 | Report Format: PDF | Published date: June 23, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 621.05 million |
|
Revenue Forecast in 2031 |
US$ 903.26 million |
|
CAGR |
4.25% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Test Type, Product, End User and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global helicobacter pylori testing market was valued at US$ 621.05 million in 2022 and is expected to register a revenue CAGR of 4.25% to reach US$ 903.26 million by 2031.
Helicobacter Pylori Testing Market Fundamentals
Helicobacter pylori testing refers to the diagnostic procedures used to detect the presence of the bacterium Helicobacter pylori (H. pylori) in the gastrointestinal tract. Helicobacter pylori is a common bacterium that can cause various gastrointestinal diseases, including gastritis, peptic ulcers, and stomach cancer. Timely and accurate testing for H. pylori is crucial for appropriate diagnosis and treatment.
Several trends are likely to contribute to the increasing demand for Helicobacter pylori (H. pylori) testing. For instance, there is a growing awareness of the association between H. pylori infection and gastrointestinal diseases, including gastritis, peptic ulcers, and stomach cancer. This increased awareness among healthcare professionals and the general population has led to a higher demand for H. pylori testing as a means of early detection and appropriate management of these conditions. Furthermore, there is a shift towards non-invasive testing methods, such as serological tests, urea breath tests (UBTs), and stool antigen tests. Compared to invasive methods like endoscopy, these tests offer advantages such as convenience, patient comfort, and ease of administration. The preference for non-invasive tests is likely to increase the uptake of H. pylori testing, especially among individuals who may be reluctant to undergo invasive procedures.
Various companies operate in the Helicobacter pylori testing market, including diagnostic test manufacturers and research institutions. Players in this industry employ diverse strategies to boost their revenue shares. Some invest in research and development to introduce innovative testing technologies and broaden their product portfolios. Moreover, companies collaborate with healthcare providers, laboratories, and academic institutions to promote testing solutions and gain market penetration.
Helicobacter Pylori Testing Market Dynamics
Increasing incidences of H. pylori infections are the major factor driving the revenue share of the global helicobacter pylori testing market. The National Center for Biotechnology Information (NCBI) reports that the prevalence of H. pylori varies between 85% and 95% in developing countries. In contrast, it ranges between 30% and 50% in developed countries. H. pylori infections are a common cause of peptic ulcers and gastritis. They can also lead to stomach cancer in some cases. As the incidence of H. pylori infections continues to rise, there is an increasing need for accurate and efficient diagnostic tests to detect and treat the infection early.
In addition, the global helicobacter pylori testing market is witnessing the introduction of new and innovative testing kits by leading manufacturers. For instance, in 2021, Otsuka introduced the QuickNavi - H.pylori, a rapid detection kit for Helicobacter pylori. This kit can identify H. pylori infection within 10 minutes, providing a quick and convenient testing solution for patients and healthcare providers. Other manufacturers, such as Biohit, Meridian Bioscience, and DiaSorin, are also investing in developing new testing kits that offer greater accuracy, reliability, and ease of use. With the growing prevalence of H. pylori infections and the increasing demand for effective diagnostic tools, the global helicobacter pylori testing market is expected to experience significant growth in the coming years.
The global helicobacter pylori testing market is predicted to witness an increase in revenue CAGR due to the increasing emphasis on preventive healthcare measures globally. Screening for H. pylori infection is an important component of preventive care, as early detection can lead to timely intervention and prevention of associated gastrointestinal diseases. As healthcare systems and individuals recognize the value of preventive measures in reducing the burden of chronic diseases, the demand for H. pylori testing is expected to rise. Governments, healthcare organizations, and insurance companies promote preventive screening programs, further contributing to market growth.
Despite the growing demand for helicobacter pylori testing, several restraining factors are impeding the revenue growth of the global helicobacter pylori testing market. Additionally, the high cost associated with helicobacter pylori testing and the limited availability of healthcare facilities in remote areas is also delaying the market's revenue growth.
Market Ecosystem
the global helicobacter pylori testing market is analyzed from the following perspectives: test type, product, and end user.
Helicobacter Pylori Testing Market by Test Type
Based on test type, the global helicobacter pylori testing market is segmented into urea breath, stool, antigen, and serology tests.
The urea breath test segment accounted for 49.65% of the global helicobacter pylori testing market share in 2022. Both patients and healthcare providers highly prefer this non-invasive diagnostic test due to its accuracy and convenience. The simplicity and speed of the test make it an ideal choice for screening and diagnosing H. pylori infections. Moreover, many top manufacturers are launching new and innovative urea breath test analyzers. For instance, in 2021, Otsuka Pharmaceutical Co., Ltd. launched a new urea breath test analyzer called "UBiT-IR300" in Japan. The device uses infrared spectroscopy technology to measure the amount of carbon dioxide produced by H. pylori bacteria in the stomach, providing quick and accurate results.
Helicobacter Pylori Testing Market by Product
Based on the product, the global helicobacter pylori testing market is segmented into point-of-care tests, and laboratory-based tests.
The laboratory-based tests segment accounts for most of the global market share. This is primarily due to the accuracy and reliability of laboratory-based tests. These tests can detect the presence of H. pylori bacteria in a patient's stool, blood, or breath samples with high accuracy, making them the preferred choice for many healthcare providers. In addition, these tests are relatively easy to perform. They can be processed quickly, promptly diagnosing and treating H. pylori infections.
The point-of-care tests segment is anticipated to register 4.85% of revenue CAGR in the forecast years. This growth can be attributed to the increasing demand for rapid and accurate diagnostic tests for helicobacter pylori infection. Point-of-care tests provide quick results and can be performed in a doctor's office and homecare settings, making them a convenient option for patients. The rising prevalence of helicobacter pylori infection globally is also driving the demand for these tests. The increasing adoption of point-of-care tests in developing countries is also expected to contribute to the growth of this segment in the helicobacter pylori testing market.
Helicobacter Pylori Testing Market by End User
Based on end user, the global helicobacter pylori testing market is segmented into hospitals, diagnostic laboratories, and others.
Hospitals largely dominate the global helicobacter pylori testing market due to the high number of patients infected with helicobacter pylori seeking medical attention. Additionally, hospitals have advanced laboratory facilities and highly trained staff, which enables accurate and timely diagnosis of H. pylori infections. The increasing number of hospital admissions and the growing demand for accurate diagnosis of H. pylori infections are expected to drive further the growth of the hospital segment in the global helicobacter pylori testing market.
Helicobacter Pylori Testing Market by Region
Based on the region, the helicobacter pylori testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for most of the global helicobacter pylori testing market in 2022. This can be attributed to the high prevalence of H. pylori infection in the region and the increasing awareness about the importance of early diagnosis and treatment of the infection. The United States and Canada are the major contributors to the market in North America, with a growing number of patients opting for non-invasive testing methods such as urea breath tests and stool antigen tests. Additionally, key market players and favorable reimbursement policies for diagnostic tests further drive the growth of the helicobacter pylori testing market in the region.
The Asia Pacific helicobacter pylori testing market is expected to register a 4.95% revenue CAGR in the forecast years. This growth is largely attributed to the increasing prevalence of H. pylori infection in the region and the rising awareness about the importance of early detection and treatment. As per the National Center for Biotechnology Information, in 2020, the prevalence of H. pylori in Asia was estimated to be around 54.7%, with varying rates across different regions and countries. The availability of advanced testing methods and technological advancements in diagnostics also contribute to the market growth. The increasing adoption of non-invasive testing methods, such as urea breath tests and stool antigen tests, is also expected to drive the demand for H. pylori testing in the region.
Strategic Development Helicobacter Pylori Testing Market
Helicobacter Pylori Testing Market Competitive Landscape
The helicobacter pylori testing market is highly competitive, with several established players. These players focus on expanding their product portfolio, investing in research and development, and engaging in strategic collaborations and partnerships to gain a competitive edge. These companies constantly strive to offer innovative and advanced diagnostic solutions to meet the growing demand for accurate and reliable H. Pylori testing.
Some of the prominent companies having the largest revenue share in the global helicobacter pylori testing market are,
Helicobacter pylori testing refers to the diagnostic procedures used to detect the presence of the bacterium Helicobacter pylori (H. pylori) in the gastrointestinal tract.
The global helicobacter pylori testing market has witnessed significant growth over the years, owing to the increasing prevalence of helicobacter infections and the introduction of new and innovative products.
The global helicobacter pylori testing market is expected to register a revenue CAGR of 4.25% in the forecast period from 2022 to 2031.
North America accounted for most of the global helicobacter pylori testing market, with most of the market revenue share in 2022. This is due to the presence of a high patient pool and the presence of many top market players in the region.
The global helicobacter pylori testing market was valued at US$ 621.05 million in 2022.
*Insights on financial performance are subject to the availability of information in the public domain